Longitudinal support for the correlative triad among aging, dopamine D2-like receptor loss, and memory decline

Nina Karalija,Goran Papenberg,Jarkko Johansson,Anders Wåhlin,Alireza Salami,Micael Andersson,Jan Axelsson,Dmitry Kuznetsov,Katrine Riklund,Martin Lövdén,Ulman Lindenberger,Lars Bäckman,Lars Nyberg
DOI: https://doi.org/10.1016/j.neurobiolaging.2024.02.001
IF: 5.133
2024-02-07
Neurobiology of Aging
Abstract:Dopamine decline is suggested to underlie aging-related cognitive decline, but longitudinal examinations of this link are currently missing. We analyzed 5-year longitudinal data for a sample of healthy, older adults (baseline: n =181, age: 64–68 years; 5-year follow-up: n =129) who underwent positron emission tomography with 11 C-raclopride to assess dopamine D2-like receptor (DRD2) availability, magnetic resonance imaging to evaluate structural brain measures, and cognitive tests. Health, lifestyle, and genetic data were also collected. A data-driven approach (k-means cluster analysis) identified groups that differed maximally in DRD2 decline rates in age-sensitive brain regions. One group (n=47) had DRD2 decline exclusively in the caudate and no cognitive decline. A second group (n=72) had more wide-ranged DRD2 decline in putamen and nucleus accumbens and also in extrastriatal regions. The latter group showed significant 5-year working memory decline that correlated with putamen DRD2 decline, along with higher dementia and cardiovascular risk and a faster biological pace of aging. Taken together, for individuals with more extensive DRD2 decline, dopamine decline is associated with memory decline in aging.
neurosciences,geriatrics & gerontology,gerontology
What problem does this paper attempt to address?